A groundbreaking study published on October 3, 2025, in the prestigious journal Aging-US sheds new light on the biochemical intricacies influencing human longevity. Led by researchers Jie V. Zhao, Yitang Sun, Junmeng Zhang, and Kaixiong Ye from the University of Hong Kong and the University of Georgia, the study rigorously explores the roles of two amino acids—phenylalanine and tyrosine—in shaping lifespan. Employing an extensive cohort analysis combined with Mendelian randomization techniques, the research uncovers compelling evidence that elevated tyrosine levels may exert a detrimental effect on male longevity, marking a significant leap in our understanding of sex-specific molecular aging processes.
Phenylalanine and tyrosine, both essential components in human metabolism, are amino acids integral to protein synthesis and neurotransmitter production. While phenylalanine is an essential amino acid obtained directly from dietary sources, tyrosine is nonessential, predominantly synthesized in the human body from phenylalanine. This biochemical relationship situates these molecules at a unique metabolic crossroads influencing neurological function and systemic physiology. Previous research hinted at their involvement in aging pathways, but lacked clarity on causality and sex-specific impacts.
The study harnessed data from an unprecedented cohort of over 270,000 participants enrolled in the UK Biobank, a resource unparalleled in scale and genetic diversity. By integrating observational epidemiology with advanced genetic instrumental variable analysis—specifically Mendelian randomization—the team systematically dissected the associations between circulating levels of these amino acids and mortality outcomes. This dual-analytical approach enables differentiation between correlation and causation, a critical advancement over traditional observational methodologies.
Initial analysis revealed that both phenylalanine and tyrosine correlated with increased mortality risk; however, further adjustment for confounding metabolic variables delineated a striking divergence. Phenylalanine’s apparent association with lifespan dissipated when accounting for tyrosine levels, implicating tyrosine as the primary driver. Remarkably, elevated tyrosine levels were found to shorten the lifespan of men by approximately one year, a robust finding consistent across multiple genetic analytic models including weighted median, weighted mode, and MR-PRESSO techniques. Contrastingly, the female cohort displayed no statistically significant associations, underscoring a profound sex-dependent effect.
This sex-specific discrepancy in tyrosine’s impact on longevity invites deeper exploration of underlying biological mechanisms. Tyrosine serves as a precursor to catecholamines such as dopamine, norepinephrine, and epinephrine—neurotransmitters integral to stress response, cognitive function, and metabolic regulation. Dysregulation in these pathways, possibly exacerbated by tyrosine overabundance, could exacerbate insulin resistance, a known driver of age-related morbidity, particularly in men. Hormonal differences between genders may further modulate these metabolic effects, contributing to men’s heightened susceptibility to tyrosine’s adverse influence.
Interestingly, population data suggest that men inherently exhibit higher circulating tyrosine levels than women, potentially establishing a biochemical substrate for the observed gender disparities in lifespan. This finding prompts crucial questions about nutritional and metabolic factors influencing amino acid homeostasis across sexes, as well as the degree to which lifestyle interventions might mitigate these risks. It also challenges the prevailing assumption that tyrosine supplementation, popular for cognitive enhancement and mood modulation, is universally benign.
The implications of these results extend beyond academic inquiry into practical public health considerations. Current dietary supplements often contain tyrosine to bolster mental acuity, especially under stress. However, this study cautions against indiscriminate supplementation, particularly for individuals with already elevated tyrosine levels or genetic predispositions influencing its metabolism. Dietary strategies such as protein intake moderation or selective amino acid restriction could emerge as viable interventions to optimize metabolic profiles conducive to longevity, although clinical trials are essential to validate these approaches.
Moreover, the research highlights the power of Mendelian randomization as a tool for unraveling complex causal links in human aging. By leveraging genetic variants associated with amino acid levels, the study effectively controls for confounding and reverse causation, circumventing limitations inherent in purely observational studies. This methodology strengthens the reliability of the findings and sets a new standard for nutritional and gerontological research moving forward.
Beyond lifespan, tyrosine’s influence on age-related pathophysiology warrants comprehensive investigation. Its roles in neurotransmission, oxidative stress modulation, and endocrine signaling suggest multifaceted interactions potentially accelerating biological aging processes in men. Identifying molecular pathways mediating these effects could unlock novel therapeutic targets, paving the way for personalized medicine strategies tailored to individual metabolic and genetic profiles.
The absence of significant phenylalanine effects after accounting for tyrosine emphasizes the nuanced hierarchy within amino acid metabolism impacting aging. This finding underscores the importance of evaluating metabolic intermediates and their interdependencies rather than isolated biomolecules when dissecting lifespan determinants. It also reinforces the necessity for integrative biochemical assessments in future epidemiological and clinical studies focused on aging.
While the current findings primarily derive from a European-descended cohort, their broad sample size and methodological rigor afford considerable generalizability. Nonetheless, replication in diverse populations is critical to affirm universality and accommodate potential variations in genetic architecture, diet, and environmental exposures that influence amino acid metabolism and longevity.
In summation, this meticulous investigation brings to the fore tyrosine as a pivotal metabolic factor modulating male lifespan, mediated through complex sex-specific biochemical and genetic mechanisms. The insights garnered herald new avenues for aging research and public health strategies aimed at enhancing lifespan and healthspan through targeted metabolic interventions. As science continues to deconstruct the molecular foundation of aging, such integrative studies hold promise for transforming our approach to personalized longevity enhancement.
Subject of Research:
Study of amino acids phenylalanine and tyrosine in relation to human longevity using cohort analysis and Mendelian randomization.
Article Title:
The role of phenylalanine and tyrosine in longevity: a cohort and Mendelian randomization study
News Publication Date:
October 3, 2025
Web References:
https://www.aging-us.com/issue/v17i10
http://dx.doi.org/10.18632/aging.206326
Image Credits:
© 2025 Zhao et al., distributed under the Creative Commons Attribution License (CC BY 4.0)
Keywords:
aging, lifespan, phenylalanine, tyrosine, Mendelian randomization, sex-specific, amino acids, metabolism, longevity, insulin resistance, neurotransmitters, gerontology
